← FDA DRUG APPROVALS
FDA ANDA · ANDA076867
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Sponsor: AIPING PHARM INC
APPLICATION
ANDA076867
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-21
LATEST ACTION
2013-03-27
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDEDiscontinued
ALBUTEROL SULFATE EQ 0.083% BASE, IPRATROPIUM BROMIDE 0.017% · SOLUTION · INHALATION
Approval history
2013-03-27Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.